Ilesol Pharmaceuticals is pleased to announce that on Monday, 4th of April 2022 our certification compliance to international standard ISO 22000:2018 audit was successfully completed.

The audit for the ISO 22000:2018 was carried out by the world-leading certification body DNV.

“This was a demanding and highly set up goal. Thanks to our quality management team and great help from Supera Kvaliteta, nothing was beyond reach. I would like to thank all the employees of Ilesol Pharmaceuticals for their contribution to this process, and for reaching another milestone for our company.

This certificate represents the crown jewel of the guarantee of sustainability, traceability, and quality of our products. With this, our clients and partners will gain on the value of their brands. New opportunities are opening up in markets like the UK, which came furthest in regulating cannabinoids as novel foods. We now further position ourselves as a worthy and strong partner in this environment,” said Robert Radosavljević, the CEO of Ilesol Pharmaceuticals.

The standard ISO 22000:2018 implies identifying the plan, operation and maintenance of the Food Safety Management System (FSMS), providing safe products and services in accordance with their intended use; demonstrating compliance with applicable statutory and regulatory food safety requirements; evaluating and assessing customer food safety requirements and demonstrating mutual conformity; effectively communicating food safety issues to interested parties within the food chain; ensuring that the organization conforms to its stated food safety policy; and demonstrating conformity to relevant interested parties.

“The whole idea of ISO 22000:2018 implementation is to improve effectiveness in enhancing the production of safe products and services while meeting applicable requirements. It involves the systematic definition and management of processes and their interactions and achieving the intended results in accordance with food safety policy and the strategic direction of the organization, ” said Marina Cindrić, the quality control and safety manager.

“For Ilesol Pharmaceuticals, the new certificates are a good addition to the so far quality systems HR ENG ISO 22716:2007 and HRN ENG ISO 9001:2015. Our company is now compliant with the international food safety regulations.”

Reviewed by Sasha Bajilo, founder of ILESOL Pharmaceuticals, an industrial scale producer of CBD products and formulations. Expert on Hemp/Cannabis policy, member of the Croatian Ministry of Health regulatory commission for medical cannabis.